Evidence map›Paper›PMID 33274585›Full record

ReviewJournal of clinical hypertension (Greenwich, Conn.)2021

Dietary intervention for the management of hypertension in Asia.

Hao-Chih Chang, Hao-Min Cheng, Chen-Huan Chen, Tzung-Dau Wang, Arieska Ann Soenarta, Yuda Turana, Boon Wee Teo, Jam Chin Tay, Kelvin Tsoi, Ji-Guang Wang and 1 more

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of clinical hypertension (Greenwich, Conn.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 6 countries.

Hao-Chih ChangDepartment of Medicine, Taipei Veterans General Hospital Su-Ao and Yuan-Shan Branch, Yilan, Taiwan.ORCID 0000-0002-6256-2194
Hao-Min ChengDepartment of Medicine, Taipei Veterans General Hospital Su-Ao and Yuan-Shan Branch, Yilan, Taiwan.ORCID 0000-0002-3885-6600
Chen-Huan ChenDepartment of Medicine, Taipei Veterans General Hospital Su-Ao and Yuan-Shan Branch, Yilan, Taiwan.ORCID 0000-0002-9262-0287
Tzung-Dau WangDivision of Cardiology, National Taiwan University Hospital, Taipei, Taiwan.ORCID 0000-0002-7180-3607
Arieska Ann SoenartaDepartment of Cardiology and Vascular Medicine, Faculty of Medicine, University of Indonesia-National Cardiovascular Center, Harapan Kita, Jakarta, Indonesia.
Yuda TuranaSchool of Medicine and Health Sciences, Atma Jaya Catholic University of Indonesia, Jakarta, Indonesia.ORCID 0000-0003-4527-0285
Boon Wee TeoDivision of Nephrology Department of Medicine, Yong Loo Lin School of Medicine, Singapore, Singapore.ORCID 0000-0002-4911-8507
Jam Chin TayDepartment of General Medicine, Tan Tock Seng Hospital, Singapore, Singapore.ORCID 0000-0001-7657-4383
Kelvin TsoiJC School of Public Health and Primary Care, The Chinese University of Hong Kong, Shatin, Hong Kong, China.ORCID 0000-0001-5580-7686
Ji-Guang WangDepartment of Hypertension, Centre for Epidemiological Studies and Clinical Trials, the Shanghai Institute of Hypertension, Shanghai Key Laboratory of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.ORCID 0000-0001-8511-1524
Kazuomi KarioDivision of Cardiovascular Medicine, Department of Medicine, Jichi Medical University School of Medicine, Tochigi, Japan.ORCID 0000-0002-8251-4480
National Yang Ming Chiao Tung University · TWAtma Jaya Catholic University of Indonesia · IDChinese University of Hong Kong · HKJichi Medical University · JPNational Taiwan University Hospital · TWPelita Harapan University · IDRuijin Hospital · CNTaipei Veterans General Hospital · TWTan Tock Seng Hospital · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertension is among the leading global risks for premature death. As the risks substantially increase along with the elevated blood pressure, a small reduction of blood pressure could have prevented numerous cardiovascular events in general population. Evidence has shown that dietary intervention is a cost-effective strategy that has been broadly advocated in the published guidelines. However, the implementation could be limited by different food cultures. This review details the mechanisms of each dietary intervention approach, evidence, and the implications in Asian populations, and the perspective of future research.

Indexed as

HypertensionAsiaBlood PressureBlood Pressure Monitoring, AmbulatoryDietHumansdietary interventionhypertension

Identifiers

PMID33274585
PMCPMC8029518
OpenAlexW3110640804

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.